Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(625)
•••
Comment by KayakerBCon Jul 19, 2016 2:16pm
80 Views
Post# 25065991

RE:RE:RE:RE:RE:RE:RE:LOL! The price action here is predictable and should have

RE:RE:RE:RE:RE:RE:RE:LOL! The price action here is predictable and should have
Mommy why is the price not going up Johnny promised us? Do I have to keep being nice mommy when he has always been wrong?

Jekyl Jr.  Little baby boy.

At the beginning of the year, most people here gave their guesses for stock price and N of deals at the end of the year.

It was just a little fun contest.  Nothing too serious for anyone (except for you).  BTW, it's an ***hole move for anyone to be criticizing anybody else's guesses.

Since the guesses for stock price cover the range from 1.47 to 36, most people will be wrong at the end of the year.  That's just the math of it.

Given that we are only half way through the year, looking at the accuracy of anyone's guess now is silly and meaningless.

For the contest, obviously people can't adjust their guesses as the year progresses.  Should everyone revise their estimates 3 days before the end of the year?

And now that I've explained it to you, we both know it was a waste of my time.  What I just explained is irrelevant to you.  Your only goal in discussing it is to use it in a personal attack against JD.  Quite pathetic and shameful of you.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities